NasdaqGS - Nasdaq Real Time Price USD

Bruker Corporation (BRKR)

Compare
67.54 -0.72 (-1.05%)
At close: September 20 at 4:00 PM EDT
66.20 -1.34 (-1.98%)
After hours: September 20 at 4:36 PM EDT
Loading Chart for BRKR
DELL
  • Previous Close 68.26
  • Open 68.26
  • Bid 67.51 x 100
  • Ask 70.84 x 100
  • Day's Range 65.82 - 68.28
  • 52 Week Range 53.79 - 94.86
  • Volume 3,577,091
  • Avg. Volume 1,071,312
  • Market Cap (intraday) 10.225B
  • Beta (5Y Monthly) 1.18
  • PE Ratio (TTM) 28.26
  • EPS (TTM) 2.39
  • Earnings Date Oct 31, 2024 - Nov 4, 2024
  • Forward Dividend & Yield 0.20 (0.30%)
  • Ex-Dividend Date Aug 30, 2024
  • 1y Target Est 77.01

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

www.bruker.com

9,707

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BRKR

View More

Performance Overview: BRKR

Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BRKR
7.89%
S&P 500
19.55%

1-Year Return

BRKR
3.69%
S&P 500
28.32%

3-Year Return

BRKR
18.26%
S&P 500
28.64%

5-Year Return

BRKR
57.45%
S&P 500
89.66%

Compare To: BRKR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BRKR

View More

Valuation Measures

Annual
As of 9/20/2024
  • Market Cap

    10.23B

  • Enterprise Value

    12.33B

  • Trailing P/E

    28.28

  • Forward P/E

    23.64

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.18

  • Price/Book (mrq)

    5.72

  • Enterprise Value/Revenue

    3.95

  • Enterprise Value/EBITDA

    19.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.29%

  • Return on Assets (ttm)

    5.48%

  • Return on Equity (ttm)

    22.86%

  • Revenue (ttm)

    3.12B

  • Net Income Avi to Common (ttm)

    352.1M

  • Diluted EPS (ttm)

    2.39

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    182.4M

  • Total Debt/Equity (mrq)

    123.38%

  • Levered Free Cash Flow (ttm)

    282.1M

Research Analysis: BRKR

View More

Company Insights: BRKR

Research Reports: BRKR

View More

People Also Watch